Science

Coffee compounds tied to cell receptor linked with stress defense

Texas A&M researchers say coffee compounds may act through NR4A1, a receptor involved in inflammation, repair and cellular stress responses.

Priya Raghavan

By Priya Raghavan · Science Reporter

3 min read

Compounds found in coffee may activate a cell receptor involved in stress response, inflammation and tissue repair, according to research from Texas A&M University. The work offers a possible biological explanation for why coffee drinking has been associated in population studies with healthier aging and lower risk of some chronic diseases.

The study, published in Nutrients, examined NR4A1, a nuclear receptor that helps regulate gene activity after stress or damage, Texas A&M said. Researchers from the university’s College of Veterinary Medicine and Biomedical Sciences reported that several coffee compounds can bind to the receptor and change its activity in laboratory models.

Dr. Stephen Safe, a distinguished professor and Sid Kyle Endowed Chair in Veterinary Toxicology at Texas A&M, said the findings suggest some of coffee’s health-related effects may depend on how its chemical components interact with NR4A1. Safe’s earlier work has described the receptor as a nutrient sensor because it can respond to compounds in the diet.

What the receptor does

Texas A&M said NR4A1 has been linked in previous studies to inflammation, metabolism and repair after tissue injury. Those processes are also involved in age-related diseases, including cancer, neurodegenerative disorders and metabolic conditions, according to the university.

In the new research, the team found that coffee’s polyhydroxy and polyphenolic compounds, including caffeic acid, were among the most active at NR4A1. In cell models, Texas A&M said those compounds reduced cellular damage and slowed cancer cell growth.

The researchers also tested what happened when NR4A1 was removed from cells. Texas A&M said the protective effects seen with the coffee compounds disappeared, strengthening the case that the receptor is involved in at least some of coffee’s biological activity.

Beyond caffeine

The findings point away from caffeine as the main actor in this pathway. Safe said caffeine can bind the receptor, but the team’s models showed much stronger activity from plant-derived compounds also found in fruits and vegetables.

Texas A&M said that result may help explain why observational studies have reported similar health associations for caffeinated and decaffeinated coffee. Those studies have linked coffee consumption with lower risk of conditions including Alzheimer’s disease, Parkinson’s disease and metabolic disease, but they do not prove that coffee prevents those illnesses.

The new study also stops short of showing direct disease prevention in people. Texas A&M described the work as a mechanistic study, meaning it was designed to test how coffee compounds act in cells and related models rather than to set advice for coffee drinkers.

Safe said coffee contains many chemicals and likely affects the body through more than one receptor or pathway. His team is also studying synthetic compounds that target NR4A1 more strongly than naturally occurring dietary compounds, with an eye toward possible treatments for cancer and other diseases, according to Texas A&M.

For consumers, the research does not change coffee guidance, Texas A&M said. Individual responses can vary with health status, caffeine sensitivity and other factors, but the findings give researchers a clearer target for studying coffee’s long-running links with aging and disease risk.

This story draws on original reporting from ScienceDaily.